UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

ERCC1/BRCA1 expression and gene polymorphisms as prognostic and predictive factors in advanced NSCLC treated with or without cisplatin

British journal of cancer, 2013-04, Vol.108 (8), p.1695-1703

2013

Volltextzugriff (PDF)

Development of type I gastric carcinoid in patients with chronic atrophic gastritis

Alimentary pharmacology & therapeutics, 2011-06, Vol.33 (12), p.1361-1369

2011

Volltextzugriff (PDF)

Risk factors for progression to gastric neoplastic lesions in patients with atrophic gastritis

Alimentary pharmacology & therapeutics, 2010-05, Vol.31 (9), p.1042-1050

2010

Volltextzugriff (PDF)

Guidelines for diagnosis and therapy of MEN type 1 and type 2

The journal of clinical endocrinology and metabolism, 2001-12, Vol.86 (12), p.5658-5671

2001

Volltextzugriff (PDF)

Gastroenteropancreatic (neuro)endocrine neoplasms: The histology report

Digestive and liver disease, 2011-03, Vol.43, p.S356-S360

2011

Volltextzugriff (PDF)

Gene expression profiles of progressive pancreatic endocrine tumours and their liver metastases reveal potential novel markers and therapeutic targets

Endocrine-related cancer, 2006-06, Vol.13 (2), p.541-558

2006

Volltextzugriff (PDF)

Highlights of the biology of endocrine tumours of the gut and pancreas

Endocrine-related cancer, 2003-12, Vol.10 (4), p.427-436

2003

Volltextzugriff (PDF)

ECL cell tumor and poorly differentiated endocrine carcinoma of the stomach: Prognostic evaluation by pathological analysis

Gastroenterology (New York, N.Y. 1943), 1999-03, Vol.116 (3), p.532-542

1999

Volltextzugriff (PDF)

Long-term clinical outcome of somatostatin analogues for treatment of progressive, metastatic, well-differentiated entero-pancreatic endocrine carcinoma

Annals of oncology, 2006-03, Vol.17 (3), p.461-466

2006

Volltextzugriff (PDF)

Long‐term follow‐up in atrophic body gastritis patients: atrophy and intestinal metaplasia are persistent lesions irrespective of Helicobacter pylori infection

Alimentary pharmacology & therapeutics, 2005-09, Vol.22 (5), p.471-481

2005

Volltextzugriff (PDF)

Biological predictive factors in rectal cancer treated with preoperative radiotherapy or radiochemotherapy

British journal of cancer, 2008-01, Vol.98 (1), p.143-147

2008

Volltextzugriff (PDF)

Multiple endocrine neoplasia (MEN)-associated tumours

Digestive and liver disease, 2004-02, Vol.36, p.S31-S34

Bordi, C

2004

Volltextzugriff (PDF)

Cure of Helicobacter pylori infection in atrophic body gastritis patients does not improve mucosal atrophy but reduces hypergastrinemia and its related effects on body ECL‐cell hyperplasia

Alimentary pharmacology & therapeutics, 2000-05, Vol.14 (5), p.625-634

2000

Volltextzugriff (PDF)

PREDICTOR FACTORS FOR REGRESSION OF ATROPHY IN PATIENTS WITH ATROPHIC BODY GASTRITIS FOLLOWING HELICOBACTER PYLORI TREATMENT

Digestive and liver disease, 2009, Vol.41, p.S14-S14

2009

Volltextzugriff (PDF)

The long‐term effects of cure of Helicobacter pylori infection on patients with atrophic body gastritis

Alimentary pharmacology & therapeutics, 2002-10, Vol.16 (10), p.1723-1731

2002

Volltextzugriff (PDF)

P.17.13 NEOPLASTIC AND NON-NEOPLASTIC COLORECTAL LESIONS IN PATIENTS WITH ATROPHIC BODY GASTRITIS

Digestive and liver disease, 2012-03, Vol.44, p.S201-S202

2012

Volltextzugriff (PDF)

P.03.11 FOXE1 AND SYNE1 GENES HYPERMETHYLATION PANEL AS PROMISING BIOMARKER IN COLITIS ASSOCIATED NEOPLASIA

Digestive and liver disease, 2013-03, Vol.45, p.S108-S109

2013

Volltextzugriff (PDF)

High prevalence of atrophic body gastritis in patients with unexplained microcytic and macrocytic anemia: A prospective screening study

The American journal of gastroenterology, 1999-03, Vol.94 (3), p.766-772

1999

Volltextzugriff (PDF)

Aggressive forms of gastric neuroendocrine tumors in multiple endocrine neoplasia type I

The American journal of surgical pathology, 1997-09, Vol.21 (9), p.1075-1082

1997

Volltextzugriff (PDF)

OC1.09.3 USEFULNESS OF GASTROPANEL FOR SCREENING OF ATROPHIC GASTRITIS IN PATIENTS WITH AUTOIMMUNE THYROID DISEASES

Digestive and liver disease, 2008, Vol.40, p.S28-S28

2008

Volltextzugriff (PDF)

Involvement of the corporal mucosa and related changes in gastric acid secretion characterize patients with iron deficiency anaemia associated with Helicobacter pylori infection

Alimentary pharmacology & therapeutics, 2001-11, Vol.15 (11), p.1753-1761

2001

Volltextzugriff (PDF)

Prognostic factors and survival in endocrine tumor patients: comparison between gastrointestinal and pancreatic localization

Endocrine-related cancer, 2005-12, Vol.12 (4), p.1083-1092

2005

Volltextzugriff (PDF)

The "Normal" Endocrine Cell of the Gut: Changing Concepts and New Evidences

Annals of the New York Academy of Sciences, 2004-04, Vol.1014 (1), p.1-12

2004

Volltextzugriff (PDF)

OC.07.1: MODULATE COLITIS SURVEILLANCE: FOXE1 AND SYNE1 HYPERMETHYLATION IN COLITIS ASSOCIATED COLORECTAL CANCER (CAC)

Digestive and liver disease, 2011, Vol.43, p.S132-S133

2011

Volltextzugriff (PDF)

OC.04.3: TYPE I GASTRIC CARCINOIDS: A PROSPECTIVE STUDY ON ENDOSCOPICMANAGEMENT AND RECURRENCE RATE

Digestive and liver disease, 2011, Vol.43, p.S126-S126

2011

Volltextzugriff (PDF)

1 – 25 von 632

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(472)
Mit Volltextzugriff
(494)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(344)
Life Sciences & Biomedicine
(260)
Humans
(245)
Male
(155)
Female
(145)
Biological And Medical Sciences
(135)
Middle Aged
(128)
Adult
(124)
Medical Sciences
(114)
Aged
(102)
Physical Sciences
(84)
Chemistry
(62)
Animals
(58)
Pathology
(58)
Chemistry, Physical
(53)
Gastroenterology & Hepatology
(48)
Gastroenterology. Liver. Pancreas. Abdomen
(39)
Stomach Neoplasms - Pathology
(39)
Biochemistry & Molecular Biology
(38)
Exact Sciences And Technology
(38)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

ERCC1/BRCA1 expression and gene polymorphisms as prognostic and predictive factors in advanced NSCLC treated with or without cisplatin

Development of type I gastric carcinoid in patients with chronic atrophic gastritis

Risk factors for progression to gastric neoplastic lesions in patients with atrophic gastritis

Guidelines for diagnosis and therapy of MEN type 1 and type 2

Gastroenteropancreatic (neuro)endocrine neoplasms: The histology report

Gene expression profiles of progressive pancreatic endocrine tumours and their liver metastases reveal potential novel markers and therapeutic targets

Highlights of the biology of endocrine tumours of the gut and pancreas

ECL cell tumor and poorly differentiated endocrine carcinoma of the stomach: Prognostic evaluation by pathological analysis

Long-term clinical outcome of somatostatin analogues for treatment of progressive, metastatic, well-differentiated entero-pancreatic endocrine carcinoma

Long‐term follow‐up in atrophic body gastritis patients: atrophy and intestinal metaplasia are persistent lesions irrespective of Helicobacter pylori infection

Biological predictive factors in rectal cancer treated with preoperative radiotherapy or radiochemotherapy

Multiple endocrine neoplasia (MEN)-associated tumours

Cure of Helicobacter pylori infection in atrophic body gastritis patients does not improve mucosal atrophy but reduces hypergastrinemia and its related effects on body ECL‐cell hyperplasia

PREDICTOR FACTORS FOR REGRESSION OF ATROPHY IN PATIENTS WITH ATROPHIC BODY GASTRITIS FOLLOWING HELICOBACTER PYLORI TREATMENT

The long‐term effects of cure of Helicobacter pylori infection on patients with atrophic body gastritis

P.17.13 NEOPLASTIC AND NON-NEOPLASTIC COLORECTAL LESIONS IN PATIENTS WITH ATROPHIC BODY GASTRITIS

P.03.11 FOXE1 AND SYNE1 GENES HYPERMETHYLATION PANEL AS PROMISING BIOMARKER IN COLITIS ASSOCIATED NEOPLASIA

High prevalence of atrophic body gastritis in patients with unexplained microcytic and macrocytic anemia: A prospective screening study

Aggressive forms of gastric neuroendocrine tumors in multiple endocrine neoplasia type I

OC1.09.3 USEFULNESS OF GASTROPANEL FOR SCREENING OF ATROPHIC GASTRITIS IN PATIENTS WITH AUTOIMMUNE THYROID DISEASES

Involvement of the corporal mucosa and related changes in gastric acid secretion characterize patients with iron deficiency anaemia associated with Helicobacter pylori infection

Prognostic factors and survival in endocrine tumor patients: comparison between gastrointestinal and pancreatic localization

The "Normal" Endocrine Cell of the Gut: Changing Concepts and New Evidences

OC.07.1: MODULATE COLITIS SURVEILLANCE: FOXE1 AND SYNE1 HYPERMETHYLATION IN COLITIS ASSOCIATED COLORECTAL CANCER (CAC)

OC.04.3: TYPE I GASTRIC CARCINOIDS: A PROSPECTIVE STUDY ON ENDOSCOPICMANAGEMENT AND RECURRENCE RATE

Suchergebnisse filtern